CatallaxCore
← Back to bills

HB 26-1336

signed

Increase Access to Pharmacy Services

Plain-English Summary

AI-generated

HB 26-1336, titled "Increase Access to Pharmacy Services," aims to expand health insurance coverage for services provided by pharmacists in Colorado. This includes allowing health benefit plans and Medicaid to cover more services that fall within a pharmacist’s scope of practice, such as certain medical consultations and treatments. The bill also prevents discrimination against pharmacists based on their license type when it comes to reimbursement and network inclusion. Additionally, the legislation updates regulations for pharmacy practices, including how pharmacies verify medication orders filled by technicians or automated systems, ensuring accuracy and quality control. Since the bill has been signed into law, these changes are now in effect, enhancing patient access to pharmacist-provided care while maintaining safety standards.

Official Summary

If certain conditions are met, the act requires health benefit plans that provide hospital, surgical, or medical expense insurance to provide reimbursement for health-care services provided by a pharmacist that are within the pharmacist's scope of practice without entering into a collaborative pharmacy practice agreement. Similarly, under the medical assistance program (medicaid), the act authorizes reimbursement for services that are within a pharmacist's scope of practice and not duplicative of other pharmacist services or programs reimbursed by medicaid.     Further, solely on the basis of the type of license or certification, a health benefit plan or health insurance company (carrier) shall not discriminate against a pharmacist who is acting within the scope of the pharmacist's license or certification under state law, with respect to participation, referral, reimbursement of covered services, or indemnification, or prohibit a pharmacist from membership in a provider network; except that, in selecting pharmacist providers, the act does not:Prohibit a health benefit plan or carrier from including providers in its provider network only to the extent necessary to meet the needs of the plan or from limiting referrals or establishing quality control measures;Require a health benefit plan or carrier to contract with any provider willing to abide by the terms and conditions for participation established by the health benefit plan or carrier; orRequire coverage for any health-care service that is not otherwise covered.     The act makes changes to the definitions in the pharmacy practice statutes to include a definition for 'final product verification'. For drug, device, or product orders that are not for controlled substances, final product verification may be delegated by a supervising pharmacist to a certified pharmacy technician or pharmacy intern. A pharmacy or other outlet shall have a continuous quality assessment system in place to periodically verify the accuracy of the final drug, device, or product and must create a plan for final product verification, including how pharmacists' hours will be maintained to provide direct patient care. The state board of pharmacy is required to adopt rules relating to final product verification no later than December 31, 2026.     Under current law, a pharmacist may administer certain tests to patients who are 12 years old or older for certain conditions and prescribe drugs to treat the tested conditions. The act adds to the definition of the 'practice of pharmacy' independent prescriptive authority for drugs that are not controlled substances, drug categories, or devices that are prescribed to patients who are 5 years old or older but under 12 years old for conditions that do not require a new diagnosis, that are minor and self-limiting, or that have a test that guides diagnosis and are not medications that may only be prescribed pursuant to a certified education program and a limited distribution network. If a pharmacist tests or treats any patient who is under 18 years old, the act requires a pharmacist to notify the patient's primary care provider consistent with health-care privacy laws or, if the patient does not have or disclose a primary care provider, refer the patient to a primary care provider for further care.(Note: This summary applies to this bill as enacted.)

Details

Chamber
House
First action
2026-05-29
Latest action
2026-03-17
Last action desc.
Introduced In House - Assigned to Health & Human Services
OpenStates
View source ↗

Sponsors

Topics

Health Care & Health InsuranceProfessions & Occupations

Related Legislation

This bill affects (26)

amends
HB 18-1112(2018A)· signed
Pharmacist Health Care Services Coverage
amends
HB 24-1045(2024A)· signed
Treatment for Substance Use Disorders
relates
SB 25-301(2025A)· signed
Remove Authorization Requirement Adjust Chronic Prescription
relates
SB 23-033(2023A)· signed
Medicaid Preauthorization Exemption
relates
HB 22-1370(2022A)· signed
Coverage Requirements For Health-care Products
relates
HB 26-1198(2026A)· signed
Access to Veterinary Care
relates
SB 25-071(2025A)· signed
Prohibit Restrictions on 340B Drugs
relates
SB 26-130(2026A)· failed
Medical Spas Deceptive Trade Practices
relates
SB 23-162(2023A)· signed
Increase Access To Pharmacy Services
relates
HB 23-1002(2023A)· signed
Epinephrine Auto-injectors
relates
SB 24-209(2024A)· signed
Pharmacy Practice Act
relates
HB 22-1095(2022A)· signed
Physician Assistant Collaboration Requirements
relates
SB 22-173(2022A)· signed
Telepharmacy Criteria Remove Location Restriction
relates
HB 22-1235(2022A)· signed
Sunset Continue Regulation Of Veterinary Practice
relates
HB 23-1164(2023A)· signed
Opioid Harm Reduction
relates
SB 23-083(2023A)· signed
Physician Assistant Collaboration Requirements
relates
SB 23-167(2023A)· signed
Board Of Nursing Regulate Certified Midwives
relates
HB 24-1149(2024A)· signed
Prior Authorization Requirements Alternatives
relates
HB 24-1037(2024A)· signed
Substance Use Disorders Harm Reduction
relates
HB 24-1045(2024A)· signed
Treatment for Substance Use Disorders
relates
SB 25-066(2025A)· signed
State Contracts with Opioid Antagonist Businesses
relates
HB 25-1222(2025A)· signed
Preserving Access to Rural Independent Pharmacies
relates
HB 24-1450(2024A)· signed
Revisor's Bill
relates
HB 26-1335(2026A)· signed
Abortion Medication Access on College Campuses
relates
HB 23-1195(2023A)· signed
Automated Pharmacy Dispensing System
relates
SB 24-110(2024A)· signed
Medicaid Prior Authorization Prohibition

Affected by (1)

relates
HB 26-1335(2026A)· signed
Abortion Medication Access on College Campuses

Votes

CONCUR
2026-05-07 · Senate · passYes: · No: · Other:
REPASS
2026-05-07 · Senate · passYes: · No: · Other:
Refer House Bill 26-1336, as amended, to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.
2026-04-30 · Senate · passYes: · No: · Other:
Adopt amendment L.008 (Attachment F).
2026-04-30 · Senate · passYes: · No: · Other:
BILL
2026-04-21 · House · passYes: · No: · Other:
Adopt amendment L.001 (Attachment B).
2026-03-31 · House · passYes: · No: · Other:
Adopt amendment L.004 (Attachment D).
2026-03-31 · House · failYes: · No: · Other:
Refer House Bill 26-1336, as amended, to the Committee of the Whole.
2026-03-31 · House · passYes: · No: · Other:
Adopt amendment L.002 (Attachment C) to L.001 (Attachment B).
2026-03-31 · House · failYes: · No: · Other: